Status:
COMPLETED
Evaluation of Some Prognostic Factors in Acute Aluminum Phosphide Intoxicated Cases
Lead Sponsor:
Zagazig University
Conditions:
Aluminum Phosphide Poisoning
Eligibility:
All Genders
15-45 years
Brief Summary
study of some laboratory and clinical findings which may show the severity of aluminium phosphide toxicity and the need of the cases to be admitted to ICU
Detailed Description
aluminium phosphide poisoning is a major cause of death in intoxicated and suicidal cases since there is no antidote and there is no specific investigation for it so there is a need for further study ...
Eligibility Criteria
Inclusion
- History of exposure or intake of Aluminum phosphide.
- Clinical picture of Acute Aluminum phosphide poisoning including severe vomiting, hypotension, abdominal pain, cardio-pulmonary distress.
- Cases of the age of 15 to 45 years old
Exclusion
- \- 1. Cases with an unclear history. 2. History of co-morbidities or systemic diseases because of the possibility of misleading laboratory results.
- 3\. History of co-ingestion of drugs or another poison.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05215444
Start Date
January 1 2021
End Date
June 30 2021
Last Update
January 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Zagazig University
Zagazig, Sharqia Province, Egypt, 44511